Indegene Ltd

Stage 2 · Advancing · week 14Setup 8.7 ★★★ PrimeEven −0.1

As of 20 Nov 2026, Indegene is in Stage 2, the uptrend phase, now in week 14 (since 13 Aug 2026). It closed at ₹658, 1.3% below its 52-week high and above its 200-day average, which is rising. In Industrials, 16.6% of stocks are in Stage 2.

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. More about the company

₹657.7
Close, 20 Nov 2026
+1.90% on the day
₹15,838 Cr · Mid cap
Market DowntrendIndustrials 16.6% in Stage 2-10.9 pts / 20dBusiness Support Services 13.0%-16.1 pts

Pro read

Pro

Our read

In a healthy advance

Setup score

8.7 ★★★ Prime

RS rank

Edge

Even −0.1

INDGN is about 3 months into its Stage 2 advance, 9% above its 50-day average and at its 52-week high. With the trend established, this middle stretch has tended to be the steadiest part of a move.

Its relative strength is 83 of 99, a leader among NSE stocks over the past year. Business Support Services ranks 47 of 106 industries by the strength of its stocks.

Stocks with a similar setup at this point in their move ran 0.1 points behind the average stock over the next 30 sessions on average, after costs, and their typical best close within 60 sessions was 15% above entry.

The trend read holds while it stays in Stage 2. A close below ₹604, its 50-day average, would put it at rest; ₹533, 20% under its 52-week high of ₹666, is where a trailing stop would sit.

Setup-score rank among Stage 2 peers: #1 of 3 in Business Support Services · #2 of 89 in Industrials

Is INDGN early, or has it already run? Pro answers that for every NSE stock, after every close.

Loading price chart…
Stage Cycle Timeline2024-05-13 → 2026-11-20
S? 41w
S4 12w
S4 39w
S2 14w
2024-05-132026-11-20
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 41w → S4 12w → S1 10w → S4 39w → S1 8w → S2 5w → S3 2w → S2 14w current
Total tracked: 132 weeks across 8 stage runs.

INDGN among Business Support Services4th of 23 by relative strength

All 23 →
Stocks in Business Support Services ranked by relative strength, with stage and one-month change
#StockStageRS1M
1KAPSTONStage 3 · wk 298+2.1%
2BLUSPRINGStage 2 · wk 2396+2.0%
3ARTEMISMEDStage 3 · wk 383+12.8%
4INDGNStage 2 · wk 1483+13.3%
5KRYSTALStage 3 · wk 373−4.3%
6SISStage 3 · wk 873−5.4%
7UDSStage 3 · wk 272+0.7%
8SANGHVIMOVStage 3 · wk 767+9.6%
vs 52W High
-1.3%
₹423.5 lo₹666.2 hi
Near 52W high
How far this stock is from its 52-week high. A stock a little below its high with its Stage 2 structure intact is in a pullback, not a breakdown.
Stage Maturity
Week 14
1w13w26w
Week 14, proven structure
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
23.5%
200 DMA: ₹532.5 · rising
The stock is above its 200-day average, the long-term trend line. That is where a Stage 2 advance normally trades.
Rel Volume
0.60x
vs 50-day avg
Volume was well below average. In a Stage 2 advance, quiet sessions read as the stock resting, not being sold.
Trend Health
↑ ⇈
Short-term trend rising strongly, and accelerating
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+13.3%
3M
+16.3%
6M
+28.0%
YTD
+26.4%
1Y
+27.9%
Sector
Industrials
↓ Peaking
Stage 2%
16.6%
20d Δ
-10.9pp
1M return
+4.4%
3M return
-5.3%
Sector Stage-2 % · last 20 days
This stock ranks #36 of 83 Stage 2 stocks in Industrials by RS.
Industry
Business Support Services
↓ Peaking
Stage 2%
13.0%
20d Δ
-16.1pp
1M return
+5.7%
3M return
+0.3%
Industry Stage-2 % · last 20 days
Ranks #2 of 3 Stage 2 stocks in this industry. Top tier.

Mutual fund holdings

Held by 37 mutual funds in portfolios to October 2026: 29 active funds and 8 index funds and ETFs.

In October, among active funds: 1 increased, 9 reduced and 1 exited.

1 increased or opened10 reduced or exited
Largest active holders, by weight in the fund
All 37 funds, the 1 that exited, and what each did in October

Mutual funds holding INDGN: the ten largest and the month’s moves →

Fund details on DiscoverMF

Scan Membership
Not in any scan now.
Last appeared 11 Nov 2026
Last appeared 13 Aug 2026
31 appearances in the last 60 days.
Recent Stage Timeline
2026-11-20S2
Wk 14 · Vol 0.60x
2026-11-19S2
Wk 14 · Vol 0.73x
2026-11-18S2
Wk 14 · Vol 0.57x
2026-11-17S2
Wk 13 · Vol 0.64x
2026-11-16S2
Wk 13 · Vol 1.39x
2026-11-13S2
Wk 13 · Vol 2.07x
2026-11-12S2
Wk 13 · Vol 4.85x
2026-11-11S2
Wk 13 · Vol 0.82x
2026-11-09S2
Wk 12 · Vol 0.32x
2026-11-06S2
Wk 12 · Vol 0.38x
2026-11-05S2
Wk 12 · Vol 0.86x
2026-11-04S2
Wk 12 · Vol 1.38x
Moving averages & range
50 DMA
₹603.9
200 DMA
₹532.5
52W High
₹666.2
52W Low
₹423.5
5D Low
₹645.4
Resistance levels (recent highs)
20d High
₹666.2
60d High
₹666.2
120d High
₹666.2
250d High
₹666.2
Next resistance
+1.3%
to 20d High
P/E (TTM)
39.2
Forward 23.7
Earnings Growth (YoY)
+9.7%
Revenue +39.6%
ROE
+13.2%
Profit margin +10.0%
Dividend Yield
0.34%
P/B 4.8

Indegene: quick answers

What stage is Indegene in?

As of 20 Nov 2026, Indegene (INDGN) is in Stage 2, the uptrend phase. It entered Stage 2 on 13 Aug 2026 and is in week 14. What the four stages mean

Is Indegene in an uptrend?

Yes. Indegene is in a Stage 2 uptrend. It trades 23.5% above its 200-day average, which is rising.

How far is Indegene from its 52-week high?

Indegene closed at ₹658 on 20 Nov 2026, 1.3% below its 52-week high of ₹666. Its 52-week low is ₹424.

How has Indegene performed over the past year?

As of 20 Nov 2026, Indegene is up 27.9% over the past year and up 26.4% so far in 2026.

Which sector and industry is Indegene in?

Indegene is in the Business Support Services industry, part of the Industrials sector. 89 stocks in Industrials are in Stage 2, 16.6% of the sector. See the Stage 2 stocks in Industrials

About this companyIndustrials· Business Support Services

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-11-20. Past data patterns are not indicative of future results. This page is a data analytics tool only.